KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Goodwill (2018 - 2025)

Twist Bioscience (TWST) has disclosed Goodwill for 5 consecutive years, with $85.8 million as the latest value for Q3 2022.

  • On a quarterly basis, Goodwill rose 282.5% to $85.8 million in Q3 2022 year-over-year; TTM through Sep 2022 was $85.8 million, a 282.5% increase, with the full-year FY2022 number at $85.8 million, up 282.5% from a year prior.
  • Goodwill was $85.8 million for Q3 2022 at Twist Bioscience, up from $84.2 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $85.8 million in Q3 2022 to a low of $1.1 million in Q3 2018.
  • A 5-year average of $16.9 million and a median of $1.1 million in 2018 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: changed 0.0% in 2019, then skyrocketed 7302.81% in 2021.
  • Twist Bioscience's Goodwill stood at $1.1 million in 2018, then changed by 0.0% to $1.1 million in 2019, then changed by 0.0% to $1.1 million in 2020, then surged by 7302.81% to $84.2 million in 2021, then increased by 1.86% to $85.8 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Goodwill are $85.8 million (Q3 2022), $84.2 million (Q4 2021), and $22.4 million (Q3 2021).